Testing effectiveness (Phase 2)Looking for participantsNCT07783802
What this trial is testing
Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Who this might be right for
AtherosclerosisCardiovascular DiseaseObesity+3 more
Eli Lilly and Company 120